bpc 157 human BPC-157 10mg – Research Peptide BPC-157: Experimental Peptide Creates Risk
Description
According to a 2017 review of Thymosin Beta-4 and rheumatoid arthritis, there are a handful of studies touting Thymosin Beta-4 exhibiting anti-inflammatory effects [13]
[DOI] [PubMed] [Google Scholar] 380
Each peptide vial typically contains 5 mg of lyophilized powder, which must be carefully mixed with bacteriostatic water to create a stable solution suitable for subcutaneous injection in research models
All dosage data is extrapolated from animal studies and clinical observation
Discreet packaging
For infants, use drop application
